Orca-Q Demonstrates Encouraging GRFS, Tolerability, and Low GVHD Incidence in Hematologic Cancers OncLive, 17 Jan 2023 Amandeep Salhotra, MD Orca-Q, a next-generation investigational cell therapy, showed reduced rates of acute and chronic graft-vs…